Past events
Third Quarter and First Nine Months 2023 Financial Results and Business Updates – Conference Call & Webcast
November 14, 2023
CureVac N.V. (Nasdaq: CVAC) has reported financial results and provided business updates for the third quarter and first nine months of 2023 on Tuesday, November 14, 2023. The company hosted a conference call and webcast on the same day.
Please find the corresponding press release and presentation slides below. A link to the replay of the webcast is available via the link below.
11th International mRNA Health Conference
October 31 - November 2, 2023
Berlin
Downloads
- Pressemitteilung
- Präsentation (Englischsprachig)
- Transkript (Englischsprachig)
Jefferies Healthcare Conference
June 7, 2023
New York
Downloads
- Pressemitteilung
- Präsentation (Englischsprachig)
- Transkript (Englischsprachig)
The JMP Securities Life Sciences Conference
May 15, 2023
New York
Downloads
- Pressemitteilung
- Präsentation (Englischsprachig)
- Transkript (Englischsprachig)
BofA Securities 2023 Health Care Conference
May 9, 2023
Las Vegas
Downloads
- Pressemitteilung
- Präsentation (Englischsprachig)
- Transkript (Englischsprachig)
VAN LANSCHOT KEMPEN Life Sciences Conference
April 26, 2023
Amsterdam
Downloads
- Pressemitteilung
- Präsentation (Englischsprachig)
- Transkript (Englischsprachig)
Fourth Quarter and Full-Year 2022 Financial Results and Business Updates – Conference Call & Webcast
April 25, 2023
CureVac N.V. (Nasdaq: CVAC), has reported financial results and provided business updates for the fourth quarter and full-year 2022 on Tuesday, April 25, 2023. The company hosted a conference call and webcast on the same day.
Please find the corresponding press release, the presentation slides and the transcript below. A link to the replay of the webcast is available via the link below.
Extraordinary general meeting of shareholders
March 28, 2023
Amsterdam
Downloads
- Pressemitteilung
- Präsentation (Englischsprachig)
- Transkript (Englischsprachig)
SVB Securities Global Biopharma Conference
February 16, 2023
Virtual
Downloads
- Pressemitteilung
- Präsentation (Englischsprachig)
- Transkript (Englischsprachig)
J.P. Morgan 41st Annual Healthcare Conference 2023 San Francisco
January 9 to 11, 2023
San Francisco
Downloads
- Pressemitteilung
- Präsentation (Englischsprachig)
- Transkript (Englischsprachig)
Conference Call & Webcast – CureVac Announces Positive Data on Joint COVID-19 and Flu mRNA Vaccine Development Programs
January 6, 2023
CureVac N.V. (Nasdaq: CVAC) today announced positive preliminary data from ongoing Phase 1 clinical programs in COVID-19 and seasonal flu, assessing both modified and unmodified mRNA technology.
The company hosted a conference call and webcast. Please find below the download link for the press release and the presentation slides as well as the link to the on demand version of the webcast.
The JMP Securities Hematology and Oncology Summit
December 6, 2022
Virtual
Downloads
- Pressemitteilung
- Präsentation (Englischsprachig)
- Transkript (Englischsprachig)
5th Annual Evercore ISI HealthCONx Conference
November 29, 2022
Virtual
Downloads
- Pressemitteilung
- Präsentation (Englischsprachig)
- Transkript (Englischsprachig)
Jefferies London Healthcare Conference
November 17, 2022
London
Downloads
- Pressemitteilung
- Präsentation (Englischsprachig)
- Transkript (Englischsprachig)
Third Quarter and First Nine Months 2022 Financial Results and Business Updates – Conference Call & Webcast
November 16, 2022
CureVac N.V. (Nasdaq: CVAC) has reported financial results and provided business updates for the third quarter and first nine months of 2022 on Wednesday, November 16, 2022. The company hosted a conference call and webcast on the same day.
Please find the corresponding press release and presentation slides below. A link to the replay of the webcast will be made available shortly.